ArticleFrontiers in pediatrics2025
Epidemiological and clinical analysis of 291 children diagnosed with
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to systematically analyze the epidemiological and clinical features of Methods: A retrospective analysis was conducted using clinical data from 291 children diagnosed with CPP who had been admitted to Hebei Children's Hospital between January 2015 and May 2025. Results: The sex distribution showed a male-to-female ratio of 187:104. The mean age was 8.12 years (range: 1 month-16 years), with an average hospital stay of 7.52 days and a mean total disease duration of 14.81 days. Annual incidence rates exhibited a progressively increasing trend, with peak seasonal occurrence observed during the winter and spring months. Age group analysis revealed the highest prevalence among children aged 7-16 years (198 cases, 68.04%), followed by infants aged 1 month-1 year (65 cases, 22.34%). Cough was the predominant clinical manifestation (141 patients, 98.60%), followed by fever (44.80% of patients; median peak temperature: 38.20 °C). Physical examination revealed pulmonary rales in 288 patients (98.97%). Laboratory findings indicated elevated white blood cell counts with neutrophil predominance, whereas C-reactive protein levels were normal or only mildly elevated. Some patients had abnormalities in coagulation profiles, myocardial enzyme levels, and immune function parameters. Polymicrobial infections were detected in 177 patients (60.82%), with rhinovirus, Conclusions: This study demonstrates that CPP exhibits distinct seasonal and age-related distribution patterns. As the clinical manifestations and routine laboratory markers offer limited diagnostic sensitivity, confirmatory testing is necessary. Our findings support PCR as a valuable diagnostic tool for this purpose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.